Filtered By:
Drug: Methylprednisolone

This page shows you your search results in order of date.

Order by Relevance | Date

Total 8 results found since Jan 2013.

A comparison of analgesic efficacy and safety of clonidine and methylprednisolone as additives to 0.25% ropivacaine in stellate ganglion block for the treatment of complex regional pain syndrome: a prospective randomised single blind study
CONCLUSIONS: The use of additives, both methylprednisolone and clonidine, is safe and effective for the SGB in CRPS. The significantly better improvement in joint mobility with methylprednisolone suggests that it should be considered promising as an additive to local anaesthetics when joint mobility is the concern.PMID:36941086 | DOI:10.3344/kjp.22299
Source: Korean Journal of Pain - March 20, 2023 Category: Anesthesiology Authors: Sreyashi Naskar Debesh Bhoi Heena Garg Maya Dehran Anjan Trikha Mohammed Tahir Ansari Source Type: research

Complex regional pain syndrome type II after cervical transforaminal epidural injection: A case report
We report a case of a 61-year-old patient who developed complex regional pain syndrome (CRPS) type II after a cervical transforaminal epidural steroid injection (CTESI). Patient concerns: The patient developed sudden-onset severe pain and swelling of his upper right limb after a cervical transforaminal epidural injection. Diagnoses: On physical examination, the patient's symptoms and signs corresponded to the Budapest criteria for CRPS. Cervical magnetic resonance imaging and laboratory tests were performed to rule out other causes. An electrodiagnostic study revealed right C6/7 radiculopathies. A three-phase bone sc...
Source: Medicine - May 1, 2018 Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research

The Need for Early Recognition of Complex Regional Pain Syndrome to Facilitate Early Effective Treatment (P7.318)
CONCLUSIONS: Early CRPS is more responsive to treatment than "established" CRPS. The diagnostic criteria of CRPS must be revised to aid in early CRPS recognition. Acknowledging allodynia, sensory manifestations and other features of the incomplete early CRPS spectrum can enhance efforts at resolving symptoms and improving function.Study Support: None.Disclosure: Dr. Laplant has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Laplant, J., Knobler, R. Tags: Pain and Palliative Care Source Type: research